Huaqing Zheng, Xiaolong Li, Xin Zeng, Chengcui Huang, Mingming Ma, Xiaofei Lv, Yajuan Zhang, Lu Sun, Guanlei Wang, Yanhua Du, Yongyuan Guan. Author correction to “TMEM16A inhibits angiotensin II-induced basilar artery smooth muscle cell migration in a WNK1-dependent manner”Acta Pharm Sin B 11(12) (2021) 3994-4007J. Acta Pharmaceutica Sinica B, 2023, 13(3): 1340-1343. DOI: 10.1016/j.apsb.2023.01.001
|
Citation:
|
Huaqing Zheng, Xiaolong Li, Xin Zeng, Chengcui Huang, Mingming Ma, Xiaofei Lv, Yajuan Zhang, Lu Sun, Guanlei Wang, Yanhua Du, Yongyuan Guan. Author correction to “TMEM16A inhibits angiotensin II-induced basilar artery smooth muscle cell migration in a WNK1-dependent manner”Acta Pharm Sin B 11(12) (2021) 3994-4007J. Acta Pharmaceutica Sinica B, 2023, 13(3): 1340-1343. DOI: 10.1016/j.apsb.2023.01.001
|
Huaqing Zheng, Xiaolong Li, Xin Zeng, Chengcui Huang, Mingming Ma, Xiaofei Lv, Yajuan Zhang, Lu Sun, Guanlei Wang, Yanhua Du, Yongyuan Guan. Author correction to “TMEM16A inhibits angiotensin II-induced basilar artery smooth muscle cell migration in a WNK1-dependent manner”Acta Pharm Sin B 11(12) (2021) 3994-4007J. Acta Pharmaceutica Sinica B, 2023, 13(3): 1340-1343. DOI: 10.1016/j.apsb.2023.01.001
|
Citation:
|
Huaqing Zheng, Xiaolong Li, Xin Zeng, Chengcui Huang, Mingming Ma, Xiaofei Lv, Yajuan Zhang, Lu Sun, Guanlei Wang, Yanhua Du, Yongyuan Guan. Author correction to “TMEM16A inhibits angiotensin II-induced basilar artery smooth muscle cell migration in a WNK1-dependent manner”Acta Pharm Sin B 11(12) (2021) 3994-4007J. Acta Pharmaceutica Sinica B, 2023, 13(3): 1340-1343. DOI: 10.1016/j.apsb.2023.01.001
|